Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis [proceedings].
D006801:Humans; D009157:Myasthenia Gravis / Q000097:blood / Q000503:physiopathology*; D009469:Neuromuscular Junction / Q000187:drug effects; D011729:Pyridostigmine Bromide / Q000097:blood* / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects
D011729:Pyridostigmine Bromide